title: Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Chao
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: Sameer.bansilal@mountsinai.org.
authors.forename: Sameer
authors.initials: S
authors.lastname: Bansilal
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D005492:Folic Acid / Q000008:administration & dosage; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D055118:Medication Adherence; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011322:Primary Prevention; D055502:Secondary Prevention; D014803:Vitamin B Complex / Q000008:administration & dosage*
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D014803:Vitamin B Complex; D005492:Folic Acid; D001241:Aspirin